首页> 外文期刊>Advances in Experimental Medicine and Biology >Next-Generation Sequencing of Hepatitis C Virus (HCV) Mixed-Genotype Infections in Anti-HCV-Negative Blood Donors
【24h】

Next-Generation Sequencing of Hepatitis C Virus (HCV) Mixed-Genotype Infections in Anti-HCV-Negative Blood Donors

机译:丙型肝炎病毒(HCV)抗HCV阴性血液供体中丙型肝炎病毒(HCV)的下一代测序

获取原文
获取原文并翻译 | 示例
       

摘要

The infection with more than one hepatitis C virus (HCV) genotype especially in subjects with a high risk of multiple HCV exposures has been demonstrated. The role of HCV mixed-genotype infection in viral persistence and treatment effect is not fully understood. The prevalence of such infection varies greatly depending on the technique used for genotype determination and studied population. Next-generation sequencing (NGS) which is suitable for extensive analysis of complex viral populations is a method of choice for studying mixed infections. The aim of the present study was to determine the prevalence of mixed-genotype HCV infections in the Polish seronegative, HCV-RNA-positive blood donors (n = 76). Two-step PCR was used for amplification of 5'-UTR of HCV. Using pyrosequencing altogether, 381,063 reads were obtained. The raw reads were trimmed and subjected to similarity analysis against the entire unfiltered NCBI nt database. Results obtained from NGS were compared with the standard genotyping. One (1.3%) mixed-genotype [3a, 2989 reads (94.8%); 1b, 164 reads (5.2%)] infection was found in a sample diagnosed as genotype 3a only by routine testing. Two samples were identified with different genotypes, compared to routine testing. In conclusion, NGS is a sensitive method for HCV genotyping. The prevalence of mixed-genotype HCV infections in blood donors is low.
机译:已经证实了具有多于一种丙型肝炎病毒(HCV)基因型的感染,特别是在具有高含HCV暴露风险的受试者中。 HCV混合基因型感染在病毒持久性和治疗效果中的作用尚不完全理解。根据用于基因型测定和研究人群的技术,这种感染的患病率大大变化。适用于复杂病毒群体广泛分析的下一代测序(NGS)是一种研究混合感染的选择方法。本研究的目的是确定波兰血清中的混合基因型HCV感染的患病率,HCV-RNA阳性献血者(n = 76)。两步PCR用于扩增HCV的5'-UTR。完全使用焦点,获得了381,063名读数。原始读取被修剪并对整个未过滤的NCBI NT数据库进行相似性分析。将NGS获得的结果与标准基因分型进行比较。一个(1.3%)混合基因型[3a,2989读数(94.8%);在仅通过常规测试仅被诊断为基因型3a的样品中发现了1b,164读取(5.2%)]感染。与常规测试相比,用不同基因型鉴定出两个样品。总之,NGS是HCV基因分型的敏感方法。献血者混合基因型HCV感染的患病率低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号